BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 16467178)

  • 1. Azithromycin in bronchiolitis obliterans: is the evidence strong enough?
    Angel LF; Levine D; Sanchez J; Levine S
    Am J Respir Crit Care Med; 2006 Feb; 173(4):465-6; author reply 466. PubMed ID: 16467178
    [No Abstract]   [Full Text] [Related]  

  • 2. Azithromycin in posttransplant bronchiolitis obliterans syndrome.
    Vos R; Vanaudenaerde BM; Verleden SE; Van Raemdonck DE; Dupont LJ; Verleden GM
    Chest; 2011 May; 139(5):1246. PubMed ID: 21540223
    [No Abstract]   [Full Text] [Related]  

  • 3. [Azithromycin as a novel treatment for bronchiolitis obliterans syndrome].
    Peled N; Shitrit D; Bendayan D; Kramer MR
    Harefuah; 2007 Mar; 146(3):219-22, 245. PubMed ID: 17460931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin in bronchiolitis obliterans complicating bone marrow transplantation: a preliminary study.
    Khalid M; Al Saghir A; Saleemi S; Al Dammas S; Zeitouni M; Al Mobeireek A; Chaudhry N; Sahovic E
    Eur Respir J; 2005 Mar; 25(3):490-3. PubMed ID: 15738293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin and bronchiolitis obliterans.
    Kanazawa S; Nomura S; Muramatsu M; Yamaguchi K; Fukuhara S
    Am J Respir Crit Care Med; 2004 Mar; 169(5):654-5; author reply 655. PubMed ID: 14982826
    [No Abstract]   [Full Text] [Related]  

  • 6. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
    Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
    Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients.
    Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR
    J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome.
    Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE
    Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation.
    Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T
    Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer?
    Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM
    J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy.
    Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM
    Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
    Verleden GM; Dupont LJ; Van Raemdonck DE
    Eur Respir J; 2005 Feb; 25(2):221-4. PubMed ID: 15684284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which patients with respiratory disease need long-term azithromycin?
    Alchakaki A; Cramer C; Patterson A; Soubani AO
    Cleve Clin J Med; 2017 Oct; 84(10):755-758. PubMed ID: 28985171
    [No Abstract]   [Full Text] [Related]  

  • 14. Obliterative bronchiolitis following lung transplantation: from old to new concepts?
    Verleden GM; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Verleden SE; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2009 Aug; 22(8):771-9. PubMed ID: 19490538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obliterative bronchiolitis in haematopoietic stem cell transplantation: can it be treated?
    Bryant DH
    Eur Respir J; 2005 Mar; 25(3):402-4. PubMed ID: 15738280
    [No Abstract]   [Full Text] [Related]  

  • 16. Azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT.
    Lemonnier F; Rivaud E; Neveu H; Catherinot E; Suarez F; Dhedin N; Couderc LJ
    Bone Marrow Transplant; 2012 Oct; 47(10):1374. PubMed ID: 22367343
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of azithromycin in bronchiolitis obliterans syndrome after hematopoietic SCT--a randomized double-blinded placebo-controlled study.
    Lam DC; Lam B; Wong MK; Lu C; Au WY; Tse EW; Leung AY; Kwong YL; Liang RH; Lam WK; Ip MS; Lie AK
    Bone Marrow Transplant; 2011 Dec; 46(12):1551-6. PubMed ID: 21317934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases and bronchiolitis obliterans: Wrapping the enigma in a riddle.
    Denlinger CE
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1203-4. PubMed ID: 25618413
    [No Abstract]   [Full Text] [Related]  

  • 19. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome.
    Yates B; Murphy DM; Forrest IA; Ward C; Rutherford RM; Fisher AJ; Lordan JL; Dark JH; Corris PA
    Am J Respir Crit Care Med; 2005 Sep; 172(6):772-5. PubMed ID: 15976371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study.
    Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM
    Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.